Doc, good post. All I have to do is turn on my TV, listen to all the side affects on drug commericals. Scarey uh. But, here's my request. Recently at the ICAD conference in Chicago was another company call Prana Biotechnology (PRAN)which I hope you or nuerolgical Doctor friends might give me your take on this company because you have the resources or insight. Yes I have stock in them, I'm not here to pump them up. They too, work on Alzheimer's disease (PBT-2). They've had write ups in the "Nueron journal" and "Lancet Nuerology journal" of which I'm not familiar with, but, you might be. I don't know if these publication are equal to the "New England journal of medicine" which seems to be well known. Prana has had good phase testing results from there PBT-2 on mice, yeah I know,not quite as complex as the human brain. However, it's a start platform from which they appear to be proactive in a preventitive nature as oppose to someone well into Alzheimer's disease. Maybe I'm reading it all wrong. Don't let the price of the stock fool you, remember Elan was in the $2.00 range at one too. I hope you'll take a moment as a fellow investor to give me your thoghts. Thank you.